Introduction
============

Acute myeloid leukemia (AML) is a deadly disease, resulting from the clonal expansion and accumulation of hematopoietic stem cells arrested at various stages of development ([@b43-btt-2-885]; [@b52-btt-2-885]). Leukemia cells are unable to undergo growth arrest, terminal differentiation and apoptosis in response to appropriate environmental stimuli, and prematurely egress from the bone marrow to disseminate into peripheral tissues ([@b43-btt-2-885]; [@b52-btt-2-885]). The standard approach to AML remains chemotherapy, and the novel agents currently available (multidrug resistance inhibitors, farnesyltransferase inhibitors, receptor kinase inhibitors, monoclonal CD33 antibody-mediated drugs) ([@b31-btt-2-885]; [@b62-btt-2-885]) show some efficacy in either monotherapy or in combination with conventional chemotherapeutic drugs such as anthracycline, cytarabine or idarubicin ([@b2-btt-2-885]; [@b38-btt-2-885]; [@b62-btt-2-885]). The development of new compounds directed against leukemia-specific targets is however needed to increase the cure rate in AML patients exhibiting chemoresistance and poor outcomes.

Allium vegetables (including garlic, onions, leeks, chives, and scallions) are used throughout the world for their sensory characteristics as well as their apparent health benefits ([@b3-btt-2-885]; [@b11-btt-2-885]; [@b47-btt-2-885]). They exhibit antimicrobial, antithrombotic, antitumor, antiarthritic and hypoglycemic properties ([@b1-btt-2-885]; [@b50-btt-2-885]; [@b29-btt-2-885]; [@b3-btt-2-885]; [@b11-btt-2-885]; [@b47-btt-2-885]) which are largely attributed to the presence of sulfur compounds in these plants ([@b37-btt-2-885]; [@b36-btt-2-885]). For example, the major sulfur-containing molecules in intact garlic are sulfoxides, which are converted into thiosulfinates (such as Allicin) when raw garlic is cut or crushed ([@b3-btt-2-885]; [@b36-btt-2-885]). Allicin (diallyl thiosulfinate/All~2~TS) ([Figure 1](#f1-btt-2-885){ref-type="fig"}) is rapidly decomposed to diallyldisulfide (DADS) ([Figure 1](#f1-btt-2-885){ref-type="fig"}), diallylsulfide (DAS) ([Figure 1](#f1-btt-2-885){ref-type="fig"}), diallyltrisulfide (DATS) ([Figure 1](#f1-btt-2-885){ref-type="fig"}) and sulfur dioxide, and therefore does not seem to be a genuine active compound of garlic ([@b3-btt-2-885]). DADS and DATS exert antiproliferative and proapoptotic effects in human epithelial cancer and neuronal cell lines ([@b60-btt-2-885]; [@b50-btt-2-885]; [@b23-btt-2-885]; [@b47-btt-2-885]; [@b66-btt-2-885], [@b68-btt-2-885]). DADS induces apoptosis in the leukemic HL-60 cell line through activation of caspase-3 ([@b34-btt-2-885]), and inhibits NO synthesis in LPS-activated macrophages ([@b24-btt-2-885]). DATS also stimulates apoptosis of HL-60 cells ([@b69-btt-2-885]) and inhibits platelet function by inhibiting platelet aggregation and Ca(2+) mobilization ([@b53-btt-2-885]). Other thiosulfinates such as dipropyl thiosulfinate (Pr~2~TS) and dimethyl thiosulfinate (Me~2~TS) ([Figure 1](#f1-btt-2-885){ref-type="fig"}) are mainly identified in onion and leek ([@b36-btt-2-885]). Pr~2~TS, Me~2~TS and All~2~TS are found to inhibit platelet aggregation through inhibition of calpain ([@b55-btt-2-885]), by reaction with surface free sulfhydryls and internal thiol-containing proteins ([@b6-btt-2-885]).

Whether Pr~2~TS, Me~2~TS and All~2~TS are able to exert chemopreventative activity against AML is presently unknown. With the above in mind, we undertook this study to evaluate the *in vitro* efficacy of these compounds on human cell lines representative of AML. We show that Pr~2~TS and Me~2~Ts, but not All~2~TS and their related sulfides, inhibit the growth of AML cell lines and interfere with the secretion of tumor necrosis factor-α (TNF-α) and matrix metalloproteinase-9 (MMP-9). Additional studies are warranted to investigate the inhibitory activity of Pr~2~TS and Me~2~TS in AML patients' cells *ex vivo*.

Materials and methods
=====================

Chemicals and antibodies
------------------------

Monoclonal antibodies (mAbs) (fluorescein isothiocyanate, FITC; phycoerythrin, PE) specific for CD11b (mIgG1, BEAR1), CD13 (mIgG1, SJ1D1), CD15 (mIgM, 80H5), CD44 (mIgG1, J-173), Apo 2.7 (mIgG1, 27AGA3), their isotypes and the Annexin V-FITC staining kit were obtained from Coulter/Beckman (Luminy, France). Irrelevant mouse (m)IgGs (FITC and PE) were obtained from R&D (Adbington, UK). Phorbol myristate acetate (PMA), nigericin, dimethyl disulfide (DMDS), dipropyl disulfide (DPDS), diallylsulfide (DAS), and diallyl disulfide (DADS) were obtained from Sigma-Aldrich (Saint Louis, MO, USA). Diallyl thiosulfinate (All~2~TS), dipropyl thiosulfinate (Pr~2~TS) and dimethyl thiosulfinate (Me~2~TS) were synthesized as previously described ([@b5-btt-2-885]). Organosulfur-compounds were solubilized in water. The stability of TS was assessed by HPLC analysis ([@b4-btt-2-885]). All-*trans* retinoic acid was provided by Ares-Serono (Geneva, Switzerland).

Human AML cell lines and cell culture
-------------------------------------

Models of AML were represented by U937 cell line (monoblastic stage, AML-M5) ([@b19-btt-2-885]) (American Tissue Cell Culture), HL-60 cell line (promyelocytic stage, AML-M2) ([@b17-btt-2-885]) (American Tissue Cell Culture), NB4 cell line (promyelocytic stage, AML-M3) ([@b35-btt-2-885]) (a gift from Dr Lanotte, Hôpital Saint Louis, Paris, France) and MonoMac-6 (promonocytic stage, AML-M5) ([@b18-btt-2-885]) (a gift from Dr Ziegler-Heitbrock, University of Munich, Germany). Cells were maintained in RPMI 1640 medium supplemented with 5% heat-inactivated fetal calf serum (FCS; Gibco, Paisley, Scotland, LPS levels \<0.1 ng/mL), 2 mM L-glutamine, 1 mM sodium pyruvate and 40 μg/ml gentamycin (Flow laboratories, Rockwell, MD) in a 5% CO~2~ humidified atmosphere at 37 °C. Cells (1--2 × 10^5^/mL) were cultured in complete RPMI 1640 medium at 37 °C in the absence or presence of various concentrations of compounds (10^−7^--10^−4^M). After various periods of incubation, cells were collected, washed twice, and living cells (with diameters ranging from 7 to 14 μm) were counted in a cell Coulter Counter ZM equipped with a Coultronic 256 channelizer (Coulter/Beckman). Maturation of cells toward the monocyte/macrophage or granulocytic pathway was determined according to the change in morphology assessed by staining cytocentrifuged cells (using a Shandon 3 Cytospin, Thermo Electron) with the Hemacolor kit from Merck and light microscope examination, and quantification of several phenotypic markers characteristic of cell maturation into macrophages (CD11b) or granulocytes (CD15, CD13, CD44) as assessed by flow cytometry analysis (see below).

Flow cytometry analysis of cell differentiation, apoptosis and death
--------------------------------------------------------------------

Intact cells were immunostained with Abs directed against CD11b, CD13, CD15, CD44 as described ([@b9-btt-2-885]). Analysis was performed in a FACS flow cytometer analyzer (Coulter-Beckman, Luminy, France). Values are given as percentages of positive cells and antigen relative density per cell (obtained by subtracting the peak channel number of the negative control from the peak channel number of the corresponding experimental sample). Apoptosis was determined by the binding of Annexin-V-FITC to phosphatidylserine exposed to the cell membrane, used in conjunction with propidium iodide (PI), to evaluate subpopulations of cells along the apoptotic pathway according to the manufacturer's instructions.

Reverse transcriptase-polymerase chain reaction (RT-PCR)
--------------------------------------------------------

RNA extraction from treated cells and cDNA synthesis were conducted as described ([@b9-btt-2-885]). Specific human primers for human β2-microglobulin, MMP9, TNF-α, and vascular endothelial growth factor (VEGF), chosen according to published sequences ([@b65-btt-2-885]; [@b9-btt-2-885]; [@b58-btt-2-885]; [@b49-btt-2-885]) were as follows: β2-microglobulin (165 bp), 5′-CAT CCA GCG TAC TCC AAA GA-3′ (forward) and 5′-GAC AAGT CTG AAT GCT CCA C-3′ (reverse); MMP-9 (296 bp), 5′- GGA GAC CTG AGA ACC AAT CTC-3′ (forward) and 5′-TCC AAT AGG TGA TGT TGT CGT-3′ (reverse); VEGF (204 bp), 5′- ACA TCT TCC AGG AGT ACC CTG ATG AG-3′ (forward) and 5'- GCA TTC ACA TTT GTT GTG CTG T-3′ (reverse); TNF-α (406 bp), 5′-ACC ATG AGC ACT GAA AGC AT-3′ (forward) and 5′-AGA TGA GGT ACA GGC CCT CT-3′ (reverse). The PCR products were visualized by electrophoresis in 2% agarose gel containing 0.2 μg/ml ethidium bromide. The β2-microglobulin gene was used to normalize the PCR products. The NIH Image 1.63 software was used for the analysis of the bands after acquisition in an Appligen densitometer (Oncor).

Measurement of MMP-9 gelatinolytic activity by zymography
---------------------------------------------------------

Analysis of MMP-9 activity was carried out in 7.5% (w/v) SDS-polyacrylamide gels containing 0.2% gelatin (w/v) as described elsewhere ([@b9-btt-2-885]). Equal amounts of culture media (20 μl) were applied to the gel in Laemmli sample buffer lacking β-mercaptoethanol. Gelatinolytic activities of pro-MMP-9 (92 kDa) and mature MMP-9 (82 kDa) were detected as transparent bands on the background of Eza-blue stained gelatin. The bands were acquired with an Appligen densitometer (Oncor).

Enzyme-linked immunosorbent assays
----------------------------------

The culture supernatant fractions from cells (10^5^ cells/mL) cultured for 3 days in the absence or presence of thiosulfinates were harvested under sterile conditions and frozen before MMP-9, VEGF, and TNF-α contents were determined using commercial ELISA kits provided by R&D (Abingdon, UK). Controls included FCS-supplemented RPMI 1640 medium alone incubated under the same conditions. The concentrations were calculated after substraction of the control values. Detection level was 10 pg/mL for TNF-α and VEGF, and 1 ng/mL for MMP-9.

Statistical analysis
--------------------

Values are represented as means ± SD of n independent experiments.

Results
=======

Pr2TS and Me2TS induce growth arrest of AML cell lines
------------------------------------------------------

The antiproliferative potential of All~2~TS, Pr~2~TS and Me~2~TS and their related sulfides (DADS, DAS, DMDS, DPDS) were first evaluated in the U937 cell line. Cells were cultured 3 days in the absence or in the presence of increasing concentrations of the compounds (10^−7^--10^−3^ M). The growth of U937 cells was inhibited by Pr~2~TS ([Figure 2A](#f2-btt-2-885){ref-type="fig"}) and Me~2~TS ([Figure 2B](#f2-btt-2-885){ref-type="fig"}) with IC~50~ values (half-maximal inhibitory concentrations) of 2 μM, whereas their related sulfides in the same range of concentration did not alter cell growth ([Figure 2C](#f2-btt-2-885){ref-type="fig"}). All~2~TS, DAS, and DADS did not affect cell growth ([Figure 2D](#f2-btt-2-885){ref-type="fig"}) and HPLC analysis showed that All~2~TS was totally degraded upon 24 h cell culture. Kinetic studies indicated also a time-dependent inhibitory effect of Pr~2~TS and Me~2~TS on cell growth ([Figure 3A](#f3-btt-2-885){ref-type="fig"}). NB4 and MonoMac-6 cell lines were also sensitive to Pr~2~TS and Me~2~TS ([Figure 3B](#f3-btt-2-885){ref-type="fig"}).

Pr2TS and Me2TS do not induce U937 cell death
---------------------------------------------

We next questioned whether the inhibition of U937 cell growth by Pr~2~TS and Me~2~TS was associated with cytotoxicity. The criteria for cell death, measured by Cell Coulter analysis, was based on the number of necrotic cells with diameters ≤7 μm (reflecting cell shrinkage), and [Figure 2A and B](#f2-btt-2-885){ref-type="fig"} shows that Pr~2~TS and Me~2~TS tested did not induce a marked cytotoxic effect. It was next investigated whether decreased growth was related to apoptosis. To this end, we analyzed the surface binding of Annexin V, known as an early marker of apoptosis ([@b42-btt-2-885]) with simultaneous PI staining for necrotic cells. [Figure 4](#f4-btt-2-885){ref-type="fig"} shows a representative experiment in which U937 cells were cultured for 3 days in the absence or presence of Pr~2~TS, Me~2~TS (5 μM) in comparison to the pro-apoptotic agent nigericin as a positive control. In contrast to untreated U937 cells ([Figure 4A](#f4-btt-2-885){ref-type="fig"}), cells treated with nigericin were strongly positive for Annexin V (L4 = 34%, [Figure 4B](#f4-btt-2-885){ref-type="fig"}, apoptotic cells) and for both Annexin V and PI (L2 = 40%, [Figure 4B](#f4-btt-2-885){ref-type="fig"}, secondary necrotic cells). U937 cells treated with Pr~2~TS or Me~2~TS were found weakly positive for Annexin V (L4 ≤14%), and for both Annexin V and PI (L2 ≤11%, [Figure 4B](#f4-btt-2-885){ref-type="fig"} and [4C](#f4-btt-2-885){ref-type="fig"}). Moreover, using Apo 2.7 antibody which reacts with a mitochondrial protein exposed on cells undergoing apoptosis, we confirmed that Pr~2~TS and Me~2~TS did not induce U937 cell apoptosis (data not shown).

Pr2TS and Me2TS induce differentiation of AML cells towards macrophages
-----------------------------------------------------------------------

The capacity of U937 cells to undergo macrophage maturation was further measured by examining the modulation of expression of the CD11b antigen and the change in morphology of stimulated cells. Enhanced CD11b expression has been associated with monocyte/macrophage differentiation ([@b30-btt-2-885]). At day 4, the block in growth of Pr~2~TS- and Me~2~TS-treated U937 cells was correlated with a marked enhanced expression of CD11b as compared to untreated cells ([Figure 5A](#f5-btt-2-885){ref-type="fig"}). In parallel, a change in morphology (increase in cell size, decrease in the nuclear/cytoplasmic ratio and apparition of vacuolisation) consistent with macrophage differentiation was observed in cells exposed to Pr~2~TS and Me~2~TS when compared to untreated cells ([Figure 5B](#f5-btt-2-885){ref-type="fig"}). As positive control, PMA-treated cells presented morphological features of cell maturation and these modifications were accompanied by the up-regulation of CD11b ([Figure 5A and B](#f5-btt-2-885){ref-type="fig"}). Similarly, Pr~2~TS and Me~2~TS induced a marked shift towards a macrophage morphology associated with the enhanced expression of CD11b in the other cell lines (data not shown).

Pr2TS and Me2TS do not induce differentiation of HL-60 and NB4 cells towards granulocytes
-----------------------------------------------------------------------------------------

Additionally, we investigated whether Pr~2~TS and Me~2~TS could also induce differentiation part of these cells towards granulocytes. Myeloblastic cell lines such as NB4 and HL-60 can be induced to differentiate into granulocyte-like cells by all-*trans* retinoic acid (ATRA) ([@b14-btt-2-885]; [@b28-btt-2-885]). Previously described changes in antigen expression by ATRA-treated cells include the increase of CD15 in HL-60 and NB4 cells ([@b35-btt-2-885]; [@b63-btt-2-885]; [@b7-btt-2-885]) and the down-regulation of CD13 and CD44 in HL-60 cells ([@b63-btt-2-885]; [@b7-btt-2-885]). Although to a lower degree, Pr~2~TS and Me~2~TS (5 μM) were capable of inhibiting HL-60 cell growth (40% inhibition at day 5). Following treatment with 10 μM ATRA for 5 days, HL-60 and NB4 cells presented morphologic features of granulocytes (data not shown) associated with the increased expression of CD15 (HL-60 and NB4) and the decreased expression of CD13 and CD44 (HL-60) ([Table 1](#t1-btt-2-885){ref-type="table"}). In contrast, cells treated with Pr~2~TS or Me~2~TS (5 μM) did not have any effect on CD13, CD15 and CD44 expression ([Table 1](#t1-btt-2-885){ref-type="table"}). Together, our results indicate that Pr~2~TS and Me~2~TS do not induce AML cells to mature along the granulocytic lineage.

Inhibitory effects of Pr2TS and Me2TS on MMP-9 and TNF-α release by U937 and NB4 cells
--------------------------------------------------------------------------------------

As assessed by ELISA and zymography analyses of the conditioned media from day 3-cultured cells, very low amounts of matrix metalloproteinase-9 (MMP-9, 92 kDa) were produced by U937 cells and NB4 cells (\<10 ng/mL). In parallel, no change in MMP-9 mRNA expression was observed to Pr~2~TS or Me~2~TS (from 24 to 72 h, data not shown). As described previously ([@b64-btt-2-885]), exposure to PMA markedly increased the levels of released MMP-9 as assessed by its gelatinolytic activity (about 10-fold increase, [Figure 6A](#f6-btt-2-885){ref-type="fig"}). Addition of Pr~2~TS or Me~2~TS (5 μM) to the culture medium resulted in a reduction of released MMP-9 activity from PMA-activated cells ([Figure 6A](#f6-btt-2-885){ref-type="fig"}). ELISA data confirmed that diminished MMP-9 gelatinolytic activity resulted from the decrease in MMP-9 protein ([Figure 6B](#f6-btt-2-885){ref-type="fig"}). PCR analysis was used to examine the steady-state MMP-9 mRNA alteration before and after Pr~2~TS or Me~2~TS treatment. As shown in [Figure 6C](#f6-btt-2-885){ref-type="fig"}, Pr~2~TS or Me~2~TS did not alter the apparent levels of MMP-9 transcripts in PMA-activated cells treated for 24 h. In parallel, the amounts of TNF-α protein released from PMA-activated cells were also strongly diminished following Pr~2~TS or Me~2~TS treatment ([Figure 7A](#f7-btt-2-885){ref-type="fig"}) while the mRNA contents of TNF-α were slightly affected by Pr~2~TS or Me~2~TS at 24 h ([Figure 7B](#f7-btt-2-885){ref-type="fig"}), TNF-α mRNA/β2 mRNA ratios being decreased by 25% for Pr~2~TS and 49% for Me~2~TS. In both cell types, vascular endothelial growth factor (VEGF) protein and mRNA levels remained almost unchanged by Pr~2~TS and Me~2~TS ([Figure 7A and B](#f7-btt-2-885){ref-type="fig"}).

Discussion
==========

Our present study provides new information about the influence of thiosulfinates (TS) in human malignant myeloid cell lines which are representative of acute myeloid leukemia cells accordingly to the French-American-British (FAB) classification. These are HL-60 (FAB M2), NB4 (FAB M3), U937 and MonoMac-6 (FAB M5) cell lines.

We first describe the ability of Pr~2~TS and Me~2~TS to inhibit in a concentration- and time-dependent manner the growth of leukemic cells *in vitro.* The comparison with their sulfide analogues (DPDS and DMDS) which do not show any influence on cell proliferation in the same range of concentration (up to 100 μM), suggests that the sulfoxide group plays a critical role in TS activity. In contrast, All~2~TS as well as its sulfide analogues DAS and DADS did not affect cell growth, and such lack of effect of All~2~TS was associated to its decomposition to sulfides as previously reported ([@b3-btt-2-885]). In contrast to our study, allylsulfides (from 10 to 100 μM) have been reported to reduce in culture and *in vivo* the growth rate of human cancer cell lines derived from solid tumors ([@b60-btt-2-885]; [@b23-btt-2-885]; [@b66-btt-2-885], [@b68-btt-2-885]; [@b47-btt-2-885]), possibly by regulating factors involved in cellular proliferation such as NF-κB ([@b50-btt-2-885]) or p21 ([@b47-btt-2-885]). Further research is required to clarify the mechanisms of inhibition of AML cell proliferation by Pr~2~TS and Me~2~TS. The mitogen-activated protein kinase (MAPK) pathway that proceeds from Ras, and its downstream effector Raf to MAPK kinase (MEK) and extracellular signal activated kinase (ERK), links various extracellular stimuli to proliferation, differentiation and survival. The MAPK signaling is constitutively active in blast cells of the majority of AML patients, and its blockade by selective small molecules inhibitors impairs leukemic cell proliferation ([@b46-btt-2-885]; [@b51-btt-2-885]). It has also to be pointed out that the level of NF-κB is high in AML ([@b8-btt-2-885]). Whether Pr~2~TS and Me~2~TS block NF-κB or MAPK activities is currently under investigation.

Organosulfur compounds may exhibit proapoptotic actions on various models of human cancers ([@b59-btt-2-885]; [@b34-btt-2-885]; [@b67-btt-2-885], [@b66-btt-2-885]; [@b21-btt-2-885]; [@b23-btt-2-885]). However, our experiments clearly indicate that Pr~2~TS and Me~2~TS do not induce cell apoptosis. Instead, the block in AML cell growth by Pr~2~TS and Me~2~TS is accompanied by differentiation of cells toward the monocyte/macrophage pathway as assessed by phenotypic and morphologic features. TNF-α is an autocrine stimulus for supporting macrophage differentiation ([@b15-btt-2-885]; [@b26-btt-2-885]). By ELISA analysis, we showed that unstimulated cells secreted very low levels of TNF-α (2 ± 0.17 pg/mL/10^5^cells) which were not altered with Pr~2~TS (1.81± 0.17 pg/mL/10^5^ cells) or Me~2~TS (1.94 ± 0.19 pg/mL/10^5^ cells ) thus indicating that endogenous TNF-α is not implicated in Pr~2~TS-/Me~2~TS-mediated cell maturation. The molecular mechanisms involved in regulating the balance between proliferation and differentiation in the monocytic/macrophage lineage remain poorly understood. The retinoblastoma gene product ([@b10-btt-2-885]), interferon regulatory factors ([@b41-btt-2-885]; [@b40-btt-2-885]) and the Ets repressor PE-1/METS ([@b57-btt-2-885]) have been reported to play a critical role in the monocytic commitment. Whether Pr~2~TS and Me~2~TS could influence the activity of these factors remains to be determined. Differentiation therapy with retinoic acid plays an important role in treating acute promyelocytic leukemia ([@b25-btt-2-885]). Our data suggests that the addition of specific agents such as Pr~2~TS or Me~2~TS to differentiation therapy could be explored.

AML is an hematological disorder which is associated with an increased angiogenesis which disappears if complete hematological remission is achieved ([@b54-btt-2-885]; [@b56-btt-2-885]; [@b39-btt-2-885]). Because of its capacities to degrade components of the extracellular matrix and angiogenic factors, MMP-9 can play a role in cancer progression by affecting tumor angiogenesis, tumor growth and/or metastasis ([@b48-btt-2-885]; [@b49-btt-2-885]; [@b16-btt-2-885]). MMP-9 is synthesized as a preproenzyme, secreted as a proform (92 kDa) and processed in a 82 kDa form resulting from the proteolytic removal of a fragment of its N-terminal domain ([@b48-btt-2-885]). AML leukemic cells express and release 92 kDa MMP-9 ([@b33-btt-2-885]). We show here that Pr~2~TS and Me~2~TS decrease MMP-9 production by activated U937 and NB4 cells. At the mRNA level, no early regulation was detectable indicating a post-transcriptional event. In connection with organosulfurs, [@b45-btt-2-885] showed that DADS inhibit the secretion of MMP-9 by HUVEC cells while not affecting MMP-9 mRNA levels. Besides MMP-9, VEGF and TNF-α are important partners of angiogenesis ([@b32-btt-2-885]; [@b61-btt-2-885]; [@b56-btt-2-885]). In addition to its angiogenic properties, VEGF may serve as an autocrine/paracrine growth factor for leukemia cells ([@b20-btt-2-885]; [@b54-btt-2-885]). TNF-α stimulates various NF-κB target genes that modulate cell survival and proliferation, tumor metastasis and angiogenesis ([@b12-btt-2-885]; [@b13-btt-2-885]). Among NF-κB target genes are MMP-9 and Bcl-2 whose proteins levels are enhanced in AML ([@b44-btt-2-885]; [@b12-btt-2-885]). A previous study showed that DADS inhibited the production of IL-1β and TNF-α by blood monocytes stimulated with lipopolysaccharide ([@b27-btt-2-885]). Our results indicate that Pr~2~TS and Me~2~TS inhibit TNF- α production by U937 and NB4 cells at the post-transcriptional level, without affecting VEGF expression. Whether Pr~2~TS and Me~2~TS inhibit the synthesis or the release of MMP-9 and TNF-α remains to be determined.

In conclusion, this work provides first evidence that Pr~2~TS and Me~2~TS may exhibit antitumor activity against AML cell lines by affecting cell growth, differentiation and secretion of factors involved in tumoral processes. Our data suggest that these TS are promising compounds for improving AML therapy. A very recent study has demonstrated selective apoptosis of childhood pre-B acute lymphoblastic leukemia cells in vitro by DATS and ajoene ([@b22-btt-2-885]) emphasizing the potential of Allium for possible treatment of human leukemias. Further studies are required to validate our observations with these TS in AML patients' cells.
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![Structure of thiosulfinates and sulfides used in this study.\
**Abbreviations:** DADS, Diallyl disulfide; DAS, diallylsulfide; All~2~TS, diallyl thiosulfinate; DMDS, dimethyl disulfide; Me~2~TS, dimethyl thiosulfinate; DPDS, dipropyl disulfide; Pr~2~TS, dipropyl thiosulfinate.](btt-2-885f1){#f1-btt-2-885}

![Dose-dependent effects of thiosulfinates and sulfides on U937 cell proliferation. Cells (10^5^/mL) were cultured for 3 days in the absence (control) or in the presence of increasing concentrations (10^−7^−10^−4^M) of Pr~2~TS (**A**), Me~2~TS (**B**), DPDS (**C**), DMDS (**C**), All~2~TS (**D**), DAS (**D**) or DADS (**D**). After 3 days, living cells and necrotic cells were counted with a cell Coulter as described in Methods. Results are expressed as % of untreated cells (100% = 9 × 10^5^ cells/mL ± 10^5^). Data represent the means of 2--5 independent determinations ± SD.](btt-2-885f2){#f2-btt-2-885}

![Time-dependent effects of Pr~2~TS and Me~2~TS on U937 cell proliferation; comparative effects with NB4 and MonoMac-6 cells. (**A**) U937 cells (10^5^/mL) were cultured in the absence or presence of 5 μM Pr~2~TS or Me~2~TS for 1 to 4 days. Results are expressed as percentage of untreated cells (100% = 9 × 10^5^ cells/mL ± 10^5^). Data represent the means of 2 to 6 independent determinations ± SD. (**B**) U937, NB4 and MonoMac-6 cells (10^5^/mL) were cultured in the absence or presence of 5 μM Pr~2~TS or Me~2~TS for 3 days (U937, NB4, MonoMac-6). Results are expressed as percentage of untreated cells. (100% = 9 × 10^5^ cells/mL ± 10^5^ for U937 and MonoMac-6; 100% = 8 × 10^5^ cells/mL ± 10^5^ for NB4). Data represent the means of n independent determinations ± SD (n = 7 to 13 for U937; n = 5 to 6 for MonoMac-6; n = 3 to 6 for NB4).](btt-2-885f3){#f3-btt-2-885}

![Representative histograms showing flow cytometry analysis of Annexin V-FITC/PI stained U937 cells. Cells were cultured in the absence (**A**) or presence of 10 μM nigericin (proapoptotic agent, positive control) (**B**), 5 μM Pr~2~TS (**C**) or 5 μM Me~2~TS (**D**) on U937 cells for 3 days. Results are expressed as log PI fluorescence intensity (y-axis) vs log Annexin V fluorescence intensity (x-axis).\
**Abbreviations:** L1, necrotic cells; L2, secondary necrotic cells; L3, healthy cells; L4, apoptotic cells; PI, propidium iodide.](btt-2-885f4){#f4-btt-2-885}

![Differentiation effects of Pr~2~TS and Me~2~TS on U937 cells. Cells (10^5^/mL) were cultured in the absence (control) or in the presence of Pr~2~TS, Me~2~TS (5 μM) or PMA (1 ng/mL) for 4 days. (**A**) Specific fluorescence intensity of CD11b antigen (black line) was detected by immunofluorescence in a Coulter flow cytometer as described in Methods. Staining of cells with a matched isotype antibody (mIgG1) served as the respective negative control (grey area). Results are expressed as relative cell number (y-axis) vs log fluorescence intensity (x-axis). Values represent percentage of positive cells. One experiment representative of four different experiments is shown. (**B**) Light microscopic morphology of U937 cells Original magnification × 600. May Grünwald stain. Scale bar, 10 μm.](btt-2-885f5){#f5-btt-2-885}

![Effects of Pr~2~TS and Me~2~TS on MMP-9 expression in PMA-activated U937 and NB4 cells. U937 and NB4 cells (10^5^/mL) activated with 1 ng/mL PMA, were cultured for 24 or 72 h in the absence or presence of Pr~2~TS and Me~2~TS (5μM). (**A**) Analysis of gelatinolytic activity in the culture media of 72 h-treated cells. The enzymatic activity of MMP-9 was analyzed using zymography performed with equal amounts of protein loaded. Gelatinolytic activities are detected as clear bands in the gel. (**B**) MMP-9 concentrations in the culture media of 72 h-treated cells were quantified by ELISA. Values are expressed as ng/mL/10^5^ cells (mean of 2 determinations ± SD). (**C**) RT-PCR analysis of MMP-9 and β2-microglobulin transcripts in 24 h-treated cells.](btt-2-885f6){#f6-btt-2-885}

![Effects of Pr~2~TS and Me~2~TS on VEGF and TNF-α expression in PMA-activated U937 and NB4 cells. U937 and NB4 cells (10^5^/mL) activated with 1 ng/mL PMA, were cultured for 24 or 72 h in the absence or presence of Pr~2~TS and Me~2~TS (5μM). (**A**) ELISA analyses of VEGF and TNF-α concentrations in culture media of 72 h-treated cells. Values are expressed as pg/mL/10^5^ cells. (**B**) RT-PCR analysis of VEGF, TNF-α and β2-microglobulin transcripts in 24 h-treated cells.](btt-2-885f7){#f7-btt-2-885}

###### 

Effects of ATRA, Pr~2~TS and Me~2~TS on the expression of CD13, CD15 and CD44 on HL-60 and NB4 cells

  Antibody antigen   Granulocyte expression   Percent of positive cells (relative density)                        
  ------------------ ------------------------ ---------------------------------------------- --------- ---------- ----------
  1\) on HL-60                                                                                                    
  CD13               ↓                        82 (30)                                        74 (17)   89 (36)    87 (36)
  CD15               ↑                        67 (35)                                        69 (84)   62 (40)    62 (27)
  CD44               ↓                        48 (168)                                       42 (28)   47 (169)   48 (197)
  2\) on NB4                                                                                                      
  CD15               ↑                        55 (17)                                        82 (98)   58 (26)    39 (16)

**Notes:** Cells cultured for 5 days in the absence (control) or presence of ATRA (10 μM), Pr~2~TS or Me~2~TS (5 μM) were assayed for expression of surface CD13, CD15 and CD44. Values are given as % of CD positive cells and CD relative density per cell (in brackets), up-regulation of CD15 ([@b35-btt-2-885]; [@b63-btt-2-885]; [@b7-btt-2-885]); down-regulation of CD13 and CD44 ([@b63-btt-2-885]; [@b7-btt-2-885]).
